OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/06/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
AVANTI RESEARCH
ST13
US500000079413997Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Patrick J. Jennings Pillsbury Winthrop Shaw Pittman, LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical compounds in the nature of lipids and lipid mixtures for scientific or research use other than for medical use; lipid compounds for scientific or research use other than for medical use; adjuvants, polymers and excipients, namely, surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, for scientific or research use other than for medical use; transfection reagents for scientific or research use other than for medical use; chemical reagents for the delivery of lipids for scientific or research use other than for medical use; standard solutions in the nature of lipids and lipid mixtures for use with analytical techniques, namely, mass spectrometry other than for medical use; lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles for all being for scientific or research use other than for medical use; fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, all being for scientific or research use other than for medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, all being for scientific or research use other than for medical use; diagnostic and analytical reagents for scientific or research use other than for medical use; formulations in the nature of liposomes, pre-mixed lipid blends and lipids for bicelle formation comprising lipids for scientific or research use other than for medical use; enzymes for scientific or research use; fluorophores and fluorescent probes for scientific or research use other than for medical use; chemical auxiliary agents as raw materials for manufacturing pharmaceutical preparations, nutrient preparations, and food supplements
Classe 5
Lipids, synthetic lipids, polymer modified lipids, lipids with modified head groups, lipids with modified acyl chains, bioactive lipids, fluorescent lipids, isotope labelled lipids, oxidized lipids, lipid extracts from natural sources, biological compounds conjugated with modified gold particles, fatty acids, glycerolipids, glycerophospholipids, sphingolipids, glycosphingolipids, saccharolipids, sterol lipids, prenol lipids, lipid preparations suitable for protein crystallization, lipid preparations suitable for protein solubilization, detergents, amphiphilic detergents, and antibodies, active agents, additives, and excipients in pharmaceutical preparations; adjuvants, polymers and excipients, namely, surfactants, dispersants, diluents, disintegrants, emulsifiers, binders, stabilisers and fillers, all of the aforesaid being for pharmaceutical or medical use; immunostimulatory compounds for pharmaceutical or medical use; isotopes for medical use; transfection reagents for pharmaceutical or medical use; amino acids, peptides, nucleosides, nucleotides and sugars, and lipid conjugated versions of the aforesaid, all being for pharmaceutical or medical use; drug delivery auxiliary agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Classe 9
Apparatus and instruments for scientific research in laboratories, namely, extruders, membranes and parts therefor
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/06/2026
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/06/2026
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/05/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
26/03/2026
FINAL DISPOSITION NOTICE SENT TO IB
05/03/2026
FINAL DISPOSITION PROCESSED
05/03/2026
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/11/2025
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/08/2025
REGISTERED-PRINCIPAL REGISTER
19/08/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBLISHED FOR OPPOSITION
01/07/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/06/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
29/05/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/05/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/05/2025
REFUSAL PROCESSED BY IB
29/03/2025
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/03/2025
REFUSAL PROCESSED BY MPU
10/03/2025
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/01/2025
NON-FINAL ACTION WRITTEN
21/01/2025
ASSIGNED TO EXAMINER
13/01/2025
APPLICATION FILING RECEIPT MAILED
10/01/2025
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2025
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2025
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.